This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirel, L.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirel, L.
Right arrow Articles by Nordmann, P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2004, p. 3831-3833, Vol. 42, No. 8
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.8.3831-3833.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vivo Acquisition of High-Level Resistance to Imipenem in Escherichia coli

Laurent Poirel, Claire Héritier, Colette Spicq, and Patrice Nordmann*

Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, South-Paris Medical School, University Paris XI, 94275 Le Kremlin-Bicêtre, France

Received 23 January 2004/ Returned for modification 24 February 2004/ Accepted 29 April 2004

Four clonally related Escherichia coli strains were isolated successively from bile duct of a girl suffering from sclerosing cholangitis. One of them, selected after an imipenem-containing regimen, was resistant to carbapenems and to broad-spectrum cephalosporins due to a plasmid-mediated cephalosporinase, CMY-2, and the lack of outer membrane proteins OmpF and OmpC.

* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 Rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France. Phone: 33 1 45 21 36 32. Fax: 33 1 45 21 63 40. E-mail: nordmann.patrice{at}bct.ap-hop-paris.fr.

Journal of Clinical Microbiology, August 2004, p. 3831-3833, Vol. 42, No. 8
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.8.3831-3833.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Poirel, L., Carrer, A., Pitout, J. D., Nordmann, P. (2009). Integron Mobilization Unit as a Source of Mobility of Antibiotic Resistance Genes. Antimicrob. Agents Chemother. 53: 2492-2498 [Abstract] [Full Text]  
  • Girlich, D., Poirel, L., Nordmann, P. (2009). CTX-M Expression and Selection of Ertapenem Resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 53: 832-834 [Abstract] [Full Text]  
  • Pavez, M., Neves, P., Dropa, M., Matte, M. H., Grinbaum, R. S., Elmor de Araujo, M. R., Mamizuka, E. M., Lincopan, N. (2008). Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC {beta}-lactamase in Brazil. J Med Microbiol 57: 1590-1592 [Full Text]  
  • Liu, Y.-F., Yan, J.-J., Ko, W.-C., Tsai, S.-H., Wu, J.-J. (2008). Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother 61: 1020-1023 [Abstract] [Full Text]  
  • Li, Y., Li, Q., Du, Y., Jiang, X., Tang, J., Wang, J., Li, G., Jiang, Y. (2008). Prevalence of Plasmid-Mediated AmpC {beta}-Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC {beta}-Lactamase Resistance in China. J. Clin. Microbiol. 46: 1317-1321 [Abstract] [Full Text]  
  • Castanheira, M., Sader, H. S., Deshpande, L. M., Fritsche, T. R., Jones, R. N. (2008). Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-{beta}-Lactamase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 52: 570-573 [Abstract] [Full Text]  
  • Vimont, S., Aubert, D., Mazoit, J.-X., Poirel, L., Nordmann, P. (2007). Broad-spectrum {beta}-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases. J Antimicrob Chemother 60: 1045-1050 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Nordmann, P. (2007). Extension of the hydrolysis spectrum of AmpC {beta}-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J Antimicrob Chemother 60: 490-494 [Abstract] [Full Text]  
  • Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L., Nordmann, P. (2005). Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49: 71-76 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»